Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals
Warren Logge, Richard W. Morris, Andrew Baillie, et al.
Psychopharmacology (2019) Vol. 238, Iss. 5, pp. 1291-1302
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex
Ahmet O. Ceceli, Charles W. Bradberry, Rita Z. Goldstein
Neuropsychopharmacology (2021) Vol. 47, Iss. 1, pp. 276-291
Open Access | Times Cited: 103
Neurobiological correlates of cue-reactivity in alcohol-use disorders: A voxel-wise meta-analysis of fMRI studies
Jianguang Zeng, Shuxian Yu, Hengyi Cao, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 294-310
Closed Access | Times Cited: 70
Baclofen for alcohol use disorder
Roberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
A meta‐analysis of the neural substrates of monetary reward anticipation and outcome in alcohol use disorder
Jianguang Zeng, Lantao You, Fan Yang, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 7, pp. 2841-2861
Open Access | Times Cited: 17
Biomarkers in alcohol use disorder - the promise and pitfalls of neuroimaging drug cue reactivity
Marlen Pfisterer, Sina Zimmermann, Judith Zaiser, et al.
Biomarkers in Neuropsychiatry (2025) Vol. 12, pp. 100119-100119
Open Access
Neural cue reactivity and intrinsic functional connectivity in individuals with alcohol use disorder following treatment with topiramate or naltrexone
Warren Logge, Paul Haber, Tristan Hurzeler, et al.
Psychopharmacology (2025)
Open Access
Cannabidiol attenuates precuneus activation during appetitive cue exposure in individuals with alcohol use disorder
Tristan Hurzeler, Warren Logge, Joshua Watt, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Open Access
Prospects for pharmacotherapies to treat alcohol use disorder
Mehdi Farokhnia, Brittney D. Browning, Lorenzo Leggio
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 4, pp. 255-265
Open Access | Times Cited: 28
The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review
Erica N. Grodin, Lara A. Ray
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 10, pp. 2038-2056
Open Access | Times Cited: 26
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology
Lindsay R. Meredith, Elizabeth M. Burnette, Steven J. Nieto, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 9, pp. 1629-1645
Closed Access | Times Cited: 7
Sex-related differences in the efficacy of Baclofen enantiomers on self-administered alcohol in a binge drinking pattern and dopamine release in the core of the nucleus accumbens
Jérôme Jeanblanc, Pierre Sauton, Charles Houdant, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review
Nicolaj Mistarz, Kjeld Andersen, Anette Søgaard Nielsen, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 608-626
Closed Access | Times Cited: 14
High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study
Kirsten C. Morley, Warren Logge, I.S. Fraser, et al.
European Neuropsychopharmacology (2021) Vol. 46, pp. 28-36
Closed Access | Times Cited: 11
Baclofen modulates cardiovascular responses to appetitive cues in treatment‐seeking alcohol use disorder individuals
Warren Logge, Andrew Baillie, Paul Haber, et al.
Human Psychopharmacology Clinical and Experimental (2020) Vol. 35, Iss. 2
Closed Access | Times Cited: 10
GABAB Receptors and Alcohol Use Disorders: Clinical Studies
Warren Logge, Kirsten C. Morley, Paul Haber
Current topics in behavioral neurosciences (2020), pp. 195-212
Closed Access | Times Cited: 9
Is R(+)‐Baclofen the best option for the future of Baclofen in alcohol dependence pharmacotherapy? Insights from the preclinical side
Víctor Echeverry‐Alzate, Jérôme Jeanblanc, Pierre Sauton, et al.
Addiction Biology (2020) Vol. 26, Iss. 2
Closed Access | Times Cited: 8
The Dopamine System in Mediating Alcohol Effects in Humans
Anne Beck, Claudia Ebrahimi, Annika Rosenthal, et al.
Current topics in behavioral neurosciences (2023)
Closed Access | Times Cited: 3
Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence
Kirsten C. Morley, Eva Louie, Tristan Hurzeler, et al.
Frontiers in Global Women s Health (2022) Vol. 3
Open Access | Times Cited: 5
Sex differences in the interrelations between stress, craving and alcohol consumption across individuals and time during baclofen treatment for alcohol dependence
Warren Logge, Andrew Baillie, Paul Haber, et al.
Addictive Behaviors (2022) Vol. 136, pp. 107462-107462
Closed Access | Times Cited: 5
Baclofen-induced Changes in the Resting Brain Modulate Smoking Cue Reactivity: A Double-blind Placebo-controlled Functional Magnetic Resonance Imaging Study in Cigarette Smokers
Ariel Ketcherside, Kanchana Jagannathan, Sudipto Dolui, et al.
Clinical Psychopharmacology and Neuroscience (2020) Vol. 18, Iss. 2, pp. 289-302
Open Access | Times Cited: 6
Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders
Bradford Martins, Will Rutland, João P. De Aquino, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 647-659
Open Access | Times Cited: 4
Effects of a novel GABA‐B positive allosteric modulator, ASP8062, on alcohol cue‐elicited craving and naturalistic alcohol consumption in a multisite randomized, double‐blind, placebo‐controlled trial
Joseph P. Schacht, Lara A. Ray, Robert Miranda, et al.
Alcohol Clinical and Experimental Research (2024) Vol. 48, Iss. 12, pp. 2352-2363
Open Access
Alcohol dependence inpatients classification with GLM and hierarchical clustering integration using fMRI data of alcohol multiple scenario cues
Abdulqawi Alarefi, Naji Alhusaini, Xunshi Wang, et al.
Experimental Brain Research (2022) Vol. 240, Iss. 10, pp. 2595-2605
Closed Access | Times Cited: 1
Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial
Patricia Pelz, Alexander Genauck, Robert C. Lorenz, et al.
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 171-183
Open Access | Times Cited: 1
Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and association with clinical outcome: Preliminary results
Warren Logge, Tristan Hurzeler, Shalini Arunogiri, et al.
Alcohol (2023) Vol. 112, pp. 25-29
Closed Access
Page 1 - Next Page

Scroll to top